Clinical trial
Evaluation of Outcomes of Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome
NCT06342999 is registered in ClinicalTrials.gov with Mauro H. Schenone as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Outcomes of Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome
- Lead sponsor
- Mauro H. Schenone
- Phase
- Not applicable
- Overall status
- Enrolling by invitation
- Start date
- January 1, 2027
- Completion date
- July 31, 2036
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.